Search

Your search keyword '"Guo-Wen, Lin"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Guo-Wen, Lin" Remove constraint Author: "Guo-Wen, Lin"
40 results on '"Guo-Wen, Lin"'

Search Results

3. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

5. External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer

6. Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer

7. [Changes in the penis size of prostate cancer patients after radical prostatectomy and its influencing factors]

8. MP24-11 LOCAL THERAPY TO THE PRIMARY TUMOR FOR NEWLY DIAGNOSED, OLIGO-METASTATIC PROSTATE CANCER: A PROSPECTIVE RANDOMIZED, PHASE 2, OPEN-LABEL TRIAL

9. Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk

12. [Attitudes of prostate cancer patients towards postoperative penile rehabilitation and their influencing factors]

14. The Value of 99mTc-PSMA SPECT/CT-Guided Surgery for Identifying and Locating Lymph Node Metastasis in Prostate Cancer Patients

15. Clinical activity of abiraterone plus prednisone in docetaxel-naοve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer

16. The Value of

17. Association of glutathione S-transferase T1 and M1 polymorphisms with prostate cancer susceptibility in populations of Asian descent: a meta-analysis

19. Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China

20. Management of Big Data in the Internet of Things in Agriculture Based on Cloud Computing

21. Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer

22. External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort

23. Tumor cytoreduction results in better response to androgen ablation—a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer

24. Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients

25. Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer

26. A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma

27. Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China

28. Clinical activity of abiraterone plus prednisone in docetaxel-naïve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer.

29. [Exploratory analysis of the effect of toxicity of sunitinib on the clinical outcome of patients with advanced renal cell carcinoma]

30. [Hematologic adverse effects in patients with renal cell carcinoma treated with sunitinib]

31. ADAM9 decreases in castration resistant prostate cancer and is a prognostic factor for overall survival

32. Comparison of accuracy among three generations of Partin tables in a Chinese cohort

34. [Establishment of regression model predicting the probability of the capsular penetration of prostate cancer]

35. [External validation of the Partin tables 2007 in Chinese prostate cancer patients]

36. [The survival analysis of metastatic prostate cancer]

37. [Experiences of open transperitoneal radical nephrectomy for large renal masses]

38. [The survival analysis of the advanced metastatic castration-resistant prostate cancer]

39. [Analysis of 36 cases of severe craniocerebral injuries complicated by severe thoracic trauma]

Catalog

Books, media, physical & digital resources